SGHT: Sight Sciences, Inc. Forward P/E Multiple

Graphic logo of sightsciences.com (SGHT)

The forward P/E dynamics on the GURU.Markets platform, as reflected in the asset value chart, stands at 0.00. Growth for Sight Sciences, Inc. (SGHT) is driven by the demand for innovative glaucoma treatment methods, the availability of insurance reimbursements, and surgeon training. The business relies on global sales, as the ophthalmology sector remains immune to trade conflicts and political sanctions.

sightsciences.com - SGHT Price to Expected Earnings Ratio (period 07/04/2022 - 11/16/2026)

Sight Sciences (SGHT) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:SGHT Sight Sciences Inc
Brand item of sightsciences.com

The forward P/E determines the investment payback period based on expected net income. This metric measures the cost of each unit of future earnings, identifying whether an asset is overvalued or undervalued. For Sight Sciences, Inc. (SGHT), this calculation depends directly on the adoption rates of ophthalmological equipment in clinics. The forward price-to-earnings ratio dynamics for Sight Sciences, Inc. (SGHT) reflect market confidence in the commercialization of glaucoma treatment systems. The stable trend on this chart confirms capital resilience.

Competitors of Sight Sciences, Inc.

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings orchestrabiomed.com (OBIO)|Anika (ANIK) - Forward Price to Earnings Multiple|InspireMD Inc. - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd ZJYL|Vivani Medical Inc - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Med)|MYO (Myomo Inc.) - Forward P/E Multiple|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO